The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of early onset colorectal cancer (EOCRC) with synchronous liver oligometastasis.
 
Oluwadunni Eunice Emiloju
Stock and Other Ownership Interests - Inovio Pharmaceuticals (I)
Consulting or Advisory Role - GlaxoSmithKline (I)
 
Mohamed Elboraey
No Relationships to Disclose
 
Seyed Ali Montazeri
No Relationships to Disclose
 
Karim Zaazoue
No Relationships to Disclose
 
Jeremy Clifton Jones
No Relationships to Disclose
 
Christina Wu
Honoraria - Cancer Treament Centers of America; Medscape; Oncology Learning Network; PrecisCA
Consulting or Advisory Role - Array BioPHarma; Daiichi Sankyo/Lilly; Natera; Natera; Nova Research Company; Pfizer; Seagen
Research Funding - Boston Biomedical (Inst); HUTCHMED; InhibRx (Inst); Lycera (Inst); Pfizer; RAPT Therapeutics (Inst); Seagen (Inst); Symphogen (Inst); Vaccinex (Inst)
 
Beau Toskich
Stock and Other Ownership Interests - Vivos Therapeutics
Honoraria - Boston Scientific (Inst); BTG (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boston Scientific (Inst); Eisai (Inst); Genentech (Inst); Histosonics (Inst); Johnson & Johnson (Inst); Sirtex Medical (Inst)
Research Funding - AstraZeneca (Inst); Boston Scientific (Inst); Genentech (Inst); Johnson and Johnson (Inst)
Travel, Accommodations, Expenses - Boston Scientific (Inst)
 
Joleen M. Hubbard
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Incyte (Inst); Incyte (Inst); Merck; Taiho Oncology (Inst)
Research Funding - Bayer (Inst); G1 Therapeutics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Pionyr (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Translational Research in Oncology (Inst); Treos Bio (Inst); Trovagene (Inst)